Sanofi SNY
NASDAQ SNY
$41.49 -0.47 (-1.13%)
As of: Oct 23, 2026 · 3:01 PM EDT

Sanofi (SNY) EBIT Margin (2009 - 2026)

Updated

Sanofi (SNY) recorded EBIT Margin of 9.03% in the quarter ended Jun 30, 2026, down 5.71 percentage points from 14.74% a year earlier and down 11.15 percentage points from the prior quarter.

Analysis

Sanofi (SNY) EBIT Margin (2009 - 2026) Analysis & Trends

On a TTM basis, Sanofi's EBIT Margin came in at 6.98% as of Jun 30, 2026, down 13.45 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 14.54%, down 3.11 percentage points from the prior year.

  • Annual EBIT Margin has declined for three straight years, with a five-year change of -24.62 percentage points (years ended Dec 2020 to Dec 2025).
  • Across earlier years, EBIT Margin came in at 17.65% in the year ended Dec 31, 2024 (-0.75 pp), 18.40% in the year ended Dec 31, 2023 (-8.59 pp), 26.99% in the year ended Dec 31, 2022 (+5.47 pp) and 21.52% in the year ended Dec 31, 2021 (-17.64 pp).
  • The figure for the quarter ended Jun 30, 2026 is the lowest quarterly EBIT Margin since the quarter ended Dec 31, 2024.
  • On a year-over-year basis, EBIT Margin rose in two of the last seven quarters, with an average year-over-year change of -16.97 percentage points.
  • Peak year-over-year performance for EBIT Margin in the last five years was a gain of 111.94 percentage points in the quarter ended Dec 31, 2023, against a drop of 143.10 percentage points in the quarter ended Dec 31, 2021 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,129.65 Bn 1,098.23 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 635.30 Bn 555.16 Bn 17.30 Bn 24.35%
3 AbbVie 504.45 Bn 477.56 Bn 12.70 Bn 37.86%
4 Merck 358.32 Bn 312.70 Bn 12.21 Bn -3.52%
5 Novartis Ag 290.03 Bn 254.02 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.08 Bn 238.77 Bn 12.86 Bn 20.57%
7 Amgen 237.81 Bn 193.21 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.88 Bn 169.07 Bn 6.22 Bn -133.21%
9 Pfizer 171.37 Bn 118.01 Bn 10.94 Bn 28.37%
10 Sanofi 50.60 Bn 17.12 Bn 10.79 Bn 9.03%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.03%
Mar 31, 2026 20.18%
Sep 30, 2025 22.84%
Jun 30, 2025 14.75%
Mar 31, 2025 23.09%
Dec 31, 2024 8.91%
Sep 30, 2024 29.11%
Jun 30, 2024 16.25%
Mar 31, 2024 13.84%
Dec 31, 2023 -10.11%
Sep 30, 2023 26.84%
Jun 30, 2023 18.66%
Mar 31, 2023 24.10%
Dec 31, 2022 38.26%
Sep 30, 2022 21.82%
Jun 30, 2022 14.16%
Mar 31, 2022 24.78%
Dec 31, 2021 14.75%
Sep 30, 2021 29.06%
Jun 30, 2021 17.60%
API Access

Sanofi EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=SNY&period=max&api_key=YOUR_API_KEY